Catalyst Wire Dossier Catalyst Wire Dossier

Olatorepatide

olatorepatide · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olatorepatide, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US [Phase 2]

See pricing